Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent Use of AGN-190584 and AGN-199201 in Presbyopia
NCT02595528Phase 2Completed
- Sponsor
- Allergan
- Start
- Apr 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pilocarpine, oxymetazoline in presbyopia, sponsored by Allergan. Started Apr 2016; status: completed.
02
Drugs
pilocarpineoxymetazoline
03
Conditions
presbyopia
Beyond the preview
Go deeper on NCT02595528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02595528.